Amneal Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.09 | $0.09 | $0.09 |
| Q2 2024 | 1 | $0.14 | $0.14 | $0.14 |
| Q3 2024 | 1 | $0.13 | $0.13 | $0.13 |
| Q4 2024 | 3 | $0.14 | $0.18 | $0.16 |
| Q1 2025 | 2 | $0.12 | $0.15 | $0.14 |
Amneal Pharmaceuticals, Inc. Earnings Date And Information
Amneal Pharmaceuticals, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $0.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.13 by $0.03. The company had revenue of 702.47 M for the quarter and had revenue of 2.39 B for the year. Amneal Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.48 diluted earnings per share) and currently has a price-to-earnings ratio of -14.95. Amneal Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 7th, 2025 based on prior year's report dates.
Amneal Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $0.04 | $690.23 M | $702.47 M | ||
| 08/09/2024 | Q2 2024 | $0.14 | $0.02 | -0.12 | $657.52 M | $701.78 M |
| 05/08/2024 | Q1 2024 | -$0.30 | $659.19 M | |||
| 03/14/2024 | Q4 2023 | -$0.40 | $616.98 M | |||
| 11/08/2023 | Q3 2023 | $0.06 | $602.60 M | $620.04 M | ||
| 08/08/2023 | Q2 2023 | $0.08 | $599.05 M | |||
| 05/09/2023 | Q1 2023 | -$0.07 | $557.54 M | |||
| 03/03/2023 | Q4 2022 | -$0.04 | $609.76 M | |||
| 11/07/2022 | Q3 2022 | -$0.02 | $545.56 M | |||
| 08/08/2022 | Q2 2022 | -$0.80 | $559.36 M | |||
| 05/06/2022 | Q1 2022 | -$0.04 | $497.63 M | |||
| 03/01/2022 | Q4 2021 | -$0.04 | $536.90 M | |||
| 11/08/2021 | Q3 2021 | -$0.03 | $528.59 M | |||
| 08/09/2021 | Q2 2021 | $0.18 | $0.10 | -0.08 | $535.08 M | |
| 05/07/2021 | Q1 2021 | $0.18 | $0.05 | -0.13 | $493.11 M | |
| 03/01/2021 | Q4 2020 | -$0.02 | $510.03 M | |||
| 11/06/2020 | Q3 2020 | $0.13 | -$0.06 | -0.19 | $519.29 M | |
| 08/06/2020 | Q2 2020 | $0.10 | -$0.08 | -0.18 | $464.66 M | |
| 05/11/2020 | Q1 2020 | $0.08 | $0.78 | 0.7 | $498.53 M | |
| 03/02/2020 | Q4 2019 | -$0.23 | $397.33 M |
Amneal Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Amneal Pharmaceuticals, Inc.'s earnings date?
Amneal Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 7th, 2025 based off last year's report dates.
-
Did Amneal Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Amneal Pharmaceuticals, Inc. (:AMRX) reported $0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $0.13 by $0.03.
-
How can I listen to Amneal Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Amneal Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Amneal Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Amneal Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Amneal Pharmaceuticals, Inc. generate each year?
Amneal Pharmaceuticals, Inc. (:AMRX) has a recorded annual revenue of $2.39 B.
-
How much profit does Amneal Pharmaceuticals, Inc. generate each year?
Amneal Pharmaceuticals, Inc. (:AMRX) has a recorded net income of $2.39 B. Amneal Pharmaceuticals, Inc. has generated $-0.48 earnings per share over the last four quarters.
-
What is Amneal Pharmaceuticals, Inc.'s price-to-earnings ratio?
Amneal Pharmaceuticals, Inc. (:AMRX) has a price-to-earnings ratio of -14.95 and price/earnings-to-growth ratio is 4.63.
